Today: 11 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar shares fell 5.9% to $20.90 in Friday’s Nasdaq session after the company reported preliminary 2025 retail sales of about 60,119 cars, up 34%, and a 27% rise in fourth-quarter volumes. The company said a December ADS ratio change restored compliance with Nasdaq’s $1 bid-price rule. CEO Michael Lohscheller set Feb. 18 for a strategy update. Europe now accounts for 78% of sales as U.S. tariffs and competition weigh.
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers shares dropped 5.3% to $32.06 after Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill. Bank of America cut its price target on Hims, citing margin and spending risks for 2026. The stock fell from an intraday high of $34.35. Investors are watching for signs of pricing pressure and updated forecasts ahead of Hims’ next earnings report.
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands shares fell 4.3% to $59.25 Friday afternoon, underperforming a rising U.S. market. Analysts cited concerns over Macau operating costs and fourth-quarter margins after Sands China and Melco Resorts dropped sharply in Hong Kong. Other casino stocks with Macau exposure also declined. Investors are watching for the company’s next results update later this month.
9 January 2026
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines shares fell 3.8% to $18.88 Friday after Stifel downgraded the stock to “hold,” citing uncertainty over a pending NASA rover contract. The stock swung between $17.82 and $19.73 on heavy volume. NASA’s Lunar Terrain Vehicle award remains undecided. Investors are also watching for U.S. inflation data on Jan. 13 and company earnings on March 19.
Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Equity Residential shares fell 3.8% to $60.46 after BMO Capital downgraded the stock, citing softening rental markets in major coastal cities. The drop followed news of a $400 million sale of three properties to JRK Property Holdings. Other large apartment REITs also traded lower. Investors are watching for upcoming U.S. inflation data and Equity Residential’s earnings on Feb. 2.
Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target

Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target

Valero shares dropped 3.2% to $185.16 Friday afternoon, underperforming other refiners as the White House met with oil firms, including Valero and Marathon, to discuss possible investment in Venezuela. Piper Sandler cut its Valero price target to $217. Oil prices rose amid global supply concerns. Investors await Valero’s Jan. 29 earnings report for margin and policy updates.
CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics shares fell 4.3% to $54.00 after a filing showed CFO Raju Prasad exercised and sold 29,700 shares under a preset trading plan. The move comes ahead of the company’s Jan. 12 slot at the J.P. Morgan Healthcare Conference and an expected mid-February earnings report. Gene-editing peers also traded lower. CASGEVY revenue and rollout remain key investor focus.
Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Costco Canada recalled certain Peace by Chocolate gift boxes sold online after a supplier warned of possible Salmonella in two pistachio chocolates. The recall affects products bought on Costco.ca between Sept. 7 and Dec. 3, with no reported illnesses as of Jan. 8. Canada’s pistachio recall list now covers over 330 products. The CFIA says its investigation is ongoing and more recalls may follow.
9 January 2026
Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Abercrombie & Fitch shares dropped 3.7% to $125.09 Friday after a weaker U.S. jobs report and mixed consumer sentiment data. UBS raised its price target on the stock to $160, citing expected 2026 earnings growth. Payrolls rose by 50,000 in December, with job losses in retail. Investors await the Fed’s Jan. 27-28 meeting and Abercrombie’s next results, expected in early March.
9 January 2026
1 266 267 268 269 270 584

Stock Market Today

  • Sugar Prices Dip After Reaching Two-Month Peak Amid Global Surplus Signals
    March 11, 2026, 4:18 PM EDT. Sugar prices fell on Tuesday as May New York raw sugar futures dropped 0.90% and May London white sugar futures declined 1.34%. The retreat followed a two-month high on Monday driven by profit-taking and a slightly stronger U.S. dollar, which pressures sugar prices. Despite a 4% rise in oil prices-usually supportive to sugar as higher oil encourages cane diversion to ethanol-sugar remains under pressure. Analysts, including Czarnikow and the International Sugar Organization (ISO), forecast a sizeable global sugar surplus for 2025/26, driven by increases in India, Thailand, and Pakistan production. India's output, up 12% year-on-year, and government-approved export quota expansions add bearish sentiment. Brazil's output showed mixed signs. The surplus outlook and export potential weigh on sugar despite some production concerns in Brazil's key region.

Latest article

XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

11 March 2026
XRP traded near $1.40, down 1.4% Wednesday, after Ripple announced plans to acquire BC Payments Australia to secure an Australian Financial Services Licence. The move comes as Australia tightens licensing rules for digital-asset firms. Broader crypto markets remained cautious amid concerns over oil prices, Iran, and U.S. inflation. Ripple’s deal is pending completion.
Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

11 March 2026
European natural gas prices held near 48 euros per megawatt hour Wednesday as Shell declared force majeure on Qatari LNG cargoes, with disruptions expected to hit from April. Asia is bidding up for replacement fuel, while Brussels considers subsidies or a price cap. LNG Canada increased shipments, but analysts warn Europe’s gas storage could end March far below average if Qatari supply issues persist.
Bitcoin Price Today: BTC Holds Above $71,000 as ETF Inflows Return, Crypto Stocks Mixed

Bitcoin Price Today: BTC Holds Above $71,000 as ETF Inflows Return, Crypto Stocks Mixed

11 March 2026
Bitcoin traded above $71,000 on Wednesday, slipping to $71,065 after a session range between $69,014 and $71,271. U.S. spot bitcoin ETFs saw $246.9 million in inflows on March 10, with BlackRock’s IBIT leading daily gains. U.S. consumer prices rose 0.3% in February, while Brent crude rebounded 4% to $91. Crypto equities were mixed; Marathon Digital fell 2.3%, Coinbase edged up 0.3%.
Go toTop